+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oral Hypoglyceimic Agent Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 112 Pages
  • January 2024
  • Region: Global
  • Prof Research
  • ID: 5922781
Description Jump to:
This report describes the global market size of Oral Hypoglyceimic Agent from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment, regional supply, demand, major players, price is presented from 2019 to 2029. This report cover following regions:
  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Oral Hypoglyceimic Agent as well as some small players. The information for each competitor include:
  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Hospitals and Clinics
  • Others

Types Segment:

  • Sulfonylureas
  • Metformin
  • Thiazolidinediones
  • Alpha-Glucosidase Inhibitors

Companies Covered:

  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Bristol-Myers Squibb
  • Novonordisk
  • Sanofi-Aventis
  • Servier
  • Huadong Medicine
  • Wanbang Biopharmaceuticals
  • Double-Crane Pharmaceutical
  • Guangzhou Pharmaceutical
  • etc.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Oral Hypoglyceimic Agent Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Oral Hypoglyceimic Agent Market in North America (2019-2029)
8.1 Oral Hypoglyceimic Agent Market Size
8.2 Oral Hypoglyceimic Agent Market by End Use
8.3 Competition by Players/Suppliers
8.4 Oral Hypoglyceimic Agent Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Oral Hypoglyceimic Agent Market in South America (2019-2029)
9.1 Oral Hypoglyceimic Agent Market Size
9.2 Oral Hypoglyceimic Agent Market by End Use
9.3 Competition by Players/Suppliers
9.4 Oral Hypoglyceimic Agent Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Oral Hypoglyceimic Agent Market in Asia & Pacific (2019-2029)
10.1 Oral Hypoglyceimic Agent Market Size
10.2 Oral Hypoglyceimic Agent Market by End Use
10.3 Competition by Players/Suppliers
10.4 Oral Hypoglyceimic Agent Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Oral Hypoglyceimic Agent Market in Europe (2019-2029)
11.1 Oral Hypoglyceimic Agent Market Size
11.2 Oral Hypoglyceimic Agent Market by End Use
11.3 Competition by Players/Suppliers
11.4 Oral Hypoglyceimic Agent Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Oral Hypoglyceimic Agent Market in MEA (2019-2029)
12.1 Oral Hypoglyceimic Agent Market Size
12.2 Oral Hypoglyceimic Agent Market by End Use
12.3 Competition by Players/Suppliers
12.4 Oral Hypoglyceimic Agent Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Oral Hypoglyceimic Agent Market (2019-2024)
13.1 Oral Hypoglyceimic Agent Market Size
13.2 Oral Hypoglyceimic Agent Market by End Use
13.3 Competition by Players/Suppliers
13.4 Oral Hypoglyceimic Agent Market Size by Type
Chapter 14 Global Oral Hypoglyceimic Agent Market Forecast (2024-2029)
14.1 Oral Hypoglyceimic Agent Market Size Forecast
14.2 Oral Hypoglyceimic Agent Application Forecast
14.3 Competition by Players/Suppliers
14.4 Oral Hypoglyceimic Agent Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Oral Hypoglyceimic Agent Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
15.2 GlaxoSmithKline
15.2.1 Company Profile
15.2.2 Main Business and Oral Hypoglyceimic Agent Information
15.2.3 SWOT Analysis of GlaxoSmithKline
15.2.4 GlaxoSmithKline Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
15.3 Bayer
15.3.1 Company Profile
15.3.2 Main Business and Oral Hypoglyceimic Agent Information
15.3.3 SWOT Analysis of Bayer
15.3.4 Bayer Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
15.4 Bristol-Myers Squibb
15.4.1 Company Profile
15.4.2 Main Business and Oral Hypoglyceimic Agent Information
15.4.3 SWOT Analysis of Bristol-Myers Squibb
15.4.4 Bristol-Myers Squibb Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
15.5 Novonordisk
15.5.1 Company Profile
15.5.2 Main Business and Oral Hypoglyceimic Agent Information
15.5.3 SWOT Analysis of Novonordisk
15.5.4 Novonordisk Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
15.6 Sanofi-Aventis
15.6.1 Company Profile
15.6.2 Main Business and Oral Hypoglyceimic Agent Information
15.6.3 SWOT Analysis of Sanofi-Aventis
15.6.4 Sanofi-Aventis Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
15.7 Servier
15.7.1 Company Profile
15.7.2 Main Business and Oral Hypoglyceimic Agent Information
15.7.3 SWOT Analysis of Servier
15.7.4 Servier Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
15.8 Huadong Medicine
15.8.1 Company Profile
15.8.2 Main Business and Oral Hypoglyceimic Agent Information
15.8.3 SWOT Analysis of Huadong Medicine
15.8.4 Huadong Medicine Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
15.9 Wanbang Biopharmaceuticals
15.9.1 Company Profile
15.9.2 Main Business and Oral Hypoglyceimic Agent Information
15.9.3 SWOT Analysis of Wanbang Biopharmaceuticals
15.9.4 Wanbang Biopharmaceuticals Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
15.10 Double-Crane Pharmaceutical
15.10.1 Company Profile
15.10.2 Main Business and Oral Hypoglyceimic Agent Information
15.10.3 SWOT Analysis of Double-Crane Pharmaceutical
15.10.4 Double-Crane Pharmaceutical Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
15.11 Guangzhou Pharmaceutical
15.11.1 Company Profile
15.11.2 Main Business and Oral Hypoglyceimic Agent Information
15.11.3 SWOT Analysis of Guangzhou Pharmaceutical
15.11.4 Guangzhou Pharmaceutical Oral Hypoglyceimic Agent Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Oral Hypoglyceimic Agent Report
Table Data Sources of Oral Hypoglyceimic Agent Report
Table Major Assumptions of Oral Hypoglyceimic Agent Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Oral Hypoglyceimic Agent Picture
Table Oral Hypoglyceimic Agent Classification
Table Oral Hypoglyceimic Agent Applications
Table Drivers of Oral Hypoglyceimic Agent Market
Table Restraints of Oral Hypoglyceimic Agent Market
Table Opportunities of Oral Hypoglyceimic Agent Market
Table Threats of Oral Hypoglyceimic Agent Market
Table COVID-19 Impact For Oral Hypoglyceimic Agent Market
Table Raw Materials Suppliers
Table Different Production Methods of Oral Hypoglyceimic Agent
Table Cost Structure Analysis of Oral Hypoglyceimic Agent
Table Key End Users
Table Latest News of Oral Hypoglyceimic Agent Market
Table Merger and Acquisition
Table Planned/Future Project of Oral Hypoglyceimic Agent Market
Table Policy of Oral Hypoglyceimic Agent Market
Table 2019-2029 North America Oral Hypoglyceimic Agent Market Size
Figure 2019-2029 North America Oral Hypoglyceimic Agent Market Size and CAGR
Table 2019-2029 North America Oral Hypoglyceimic Agent Market Size by Application
Table 2019-2024 North America Oral Hypoglyceimic Agent Key Players Revenue
Table 2019-2024 North America Oral Hypoglyceimic Agent Key Players Market Share
Table 2019-2029 North America Oral Hypoglyceimic Agent Market Size by Type
Table 2019-2029 United States Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Canada Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Mexico Oral Hypoglyceimic Agent Market Size
Table 2019-2029 South America Oral Hypoglyceimic Agent Market Size
Figure 2019-2029 South America Oral Hypoglyceimic Agent Market Size and CAGR
Table 2019-2029 South America Oral Hypoglyceimic Agent Market Size by Application
Table 2019-2024 South America Oral Hypoglyceimic Agent Key Players Revenue
Table 2019-2024 South America Oral Hypoglyceimic Agent Key Players Market Share
Table 2019-2029 South America Oral Hypoglyceimic Agent Market Size by Type
Table 2019-2029 Brazil Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Argentina Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Chile Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Peru Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Asia & Pacific Oral Hypoglyceimic Agent Market Size
Figure 2019-2029 Asia & Pacific Oral Hypoglyceimic Agent Market Size and CAGR
Table 2019-2029 Asia & Pacific Oral Hypoglyceimic Agent Market Size by Application
Table 2019-2024 Asia & Pacific Oral Hypoglyceimic Agent Key Players Revenue
Table 2019-2024 Asia & Pacific Oral Hypoglyceimic Agent Key Players Market Share
Table 2019-2029 Asia & Pacific Oral Hypoglyceimic Agent Market Size by Type
Table 2019-2029 China Oral Hypoglyceimic Agent Market Size
Table 2019-2029 India Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Japan Oral Hypoglyceimic Agent Market Size
Table 2019-2029 South Korea Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Southeast Asia Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Australia Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Europe Oral Hypoglyceimic Agent Market Size
Figure 2019-2029 Europe Oral Hypoglyceimic Agent Market Size and CAGR
Table 2019-2029 Europe Oral Hypoglyceimic Agent Market Size by Application
Table 2019-2024 Europe Oral Hypoglyceimic Agent Key Players Revenue
Table 2019-2024 Europe Oral Hypoglyceimic Agent Key Players Market Share
Table 2019-2029 Europe Oral Hypoglyceimic Agent Market Size by Type
Table 2019-2029 Germany Oral Hypoglyceimic Agent Market Size
Table 2019-2029 France Oral Hypoglyceimic Agent Market Size
Table 2019-2029 United Kingdom Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Italy Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Spain Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Belgium Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Netherlands Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Austria Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Poland Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Russia Oral Hypoglyceimic Agent Market Size
Table 2019-2029 MEA Oral Hypoglyceimic Agent Market Size
Figure 2019-2029 MEA Oral Hypoglyceimic Agent Market Size and CAGR
Table 2019-2029 MEA Oral Hypoglyceimic Agent Market Size by Application
Table 2019-2024 MEA Oral Hypoglyceimic Agent Key Players Revenue
Table 2019-2024 MEA Oral Hypoglyceimic Agent Key Players Market Share
Table 2019-2029 MEA Oral Hypoglyceimic Agent Market Size by Type
Table 2019-2029 Egypt Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Israel Oral Hypoglyceimic Agent Market Size
Table 2019-2029 South Africa Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Gulf Cooperation Council Countries Oral Hypoglyceimic Agent Market Size
Table 2019-2029 Turkey Oral Hypoglyceimic Agent Market Size
Table 2019-2024 Global Oral Hypoglyceimic Agent Market Size by Region
Table 2019-2024 Global Oral Hypoglyceimic Agent Market Size Share by Region
Table 2019-2024 Global Oral Hypoglyceimic Agent Market Size by Application
Table 2019-2024 Global Oral Hypoglyceimic Agent Market Share by Application
Table 2019-2024 Global Oral Hypoglyceimic Agent Key Vendors Revenue
Figure 2019-2024 Global Oral Hypoglyceimic Agent Market Size and Growth Rate
Table 2019-2024 Global Oral Hypoglyceimic Agent Key Vendors Market Share
Table 2019-2024 Global Oral Hypoglyceimic Agent Market Size by Type
Table 2019-2024 Global Oral Hypoglyceimic Agent Market Share by Type
Table 2024-2029 Global Oral Hypoglyceimic Agent Market Size by Region
Table 2024-2029 Global Oral Hypoglyceimic Agent Market Size Share by Region
Table 2024-2029 Global Oral Hypoglyceimic Agent Market Size by Application
Table 2024-2029 Global Oral Hypoglyceimic Agent Market Share by Application
Table 2024-2029 Global Oral Hypoglyceimic Agent Key Vendors Revenue
Figure 2024-2029 Global Oral Hypoglyceimic Agent Market Size and Growth Rate
Table 2024-2029 Global Oral Hypoglyceimic Agent Key Vendors Market Share
Table 2024-2029 Global Oral Hypoglyceimic Agent Market Size by Type
Table 2024-2029 Oral Hypoglyceimic Agent Global Market Share by Type

Companies Mentioned

  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Bristol-Myers Squibb
  • Novonordisk
  • Sanofi-Aventis
  • Servier
  • Huadong Medicine
  • Wanbang Biopharmaceuticals
  • Double-Crane Pharmaceutical
  • Guangzhou Pharmaceutical

Related Topics

Related Reports

Oral Hypoglycemic Agents Market Report 2025 - Product Image

Oral Hypoglycemic Agents Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Diabetes Therapeutics Market Report 2025 - Product Image

Diabetes Therapeutics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 142 Pages
  • Global
From
Diabetes Drugs Market - Global Forecast 2025-2032 - Product Image

Diabetes Drugs Market - Global Forecast 2025-2032

  • Report
  • 186 Pages
  • Global
From
Empagliflozin Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Empagliflozin Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.